CFDE Data Portal | Search RPL9P28

	Label	Description
	RPL9P28 associations Collection (Entity type)	Associations for RPL9P28_associations
	RPL9P28 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	RPL9P28 Gene (Entity type)	ENSG00000242067 - ribosomal protein L9 pseudogene 28
	GSE119369 H10 inhibition 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE240741 L-13 TIME 4 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119369 H10 inhibition 1 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE210093 TAF15 overexpression A-549 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE81796 enzalutamide LNCaP C4-2 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Vagina 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Pituitary 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx

RPL9P28 associations

Associations for RPL9P28_associations

RPL9P28 associations.tsv

A file from IDG as part of the Harmonizome project

RPL9P28

ENSG00000242067 - ribosomal protein L9 pseudogene 28

GSE119369 H10 inhibition 1 v 5 human up

A Gene Set from LINCS

GSE240741 L-13 TIME 4 v 6 human dn

A Gene Set from LINCS

GSE119369 H10 inhibition 1 v 6 human up

A Gene Set from LINCS

GSE210093 TAF15 overexpression A-549 0 v 2 human up

A Gene Set from LINCS

GSE81796 enzalutamide LNCaP C4-2 0 v 2 human dn

A Gene Set from LINCS

GTEx Vagina 20-29 vs 30-39 Down

A Gene Set from GTEx

GTEx Pituitary 20-29 vs 30-39 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.